The Role of Arnica on Muscle Pain Following Eccentric Exercise

Exercise Clinical Trial

— Arnica  

Official title:

The Role of Arnica on Muscle Pain Following Eccentric Exercise

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00504010
• Other study ID #: HSC-MH-07-0202
• Status: Completed
• Phase: Phase 1
• First received: July 17, 2007
• Last updated: January 6, 2009
• Start date: August 2007
• Est. completion date: September 2008

Study information

• Verified date: January 2009
• Source: The University of Texas Health Science Center, Houston
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

Arnica in a topical gel formulation will be compared to a placebo to determine whether it decreases muscle soreness following leg exercise when applied to the legs.

Description:

Design: The design is a randomized, placebo-controlled, double-blind trial. Each participant will receive 2 containers of gel. One container will be marked "LEFT" and one "RIGHT." One container will contain a commercially available arnica gel formulation, and the other will contain a placebo gel, identical in appearance to the arnica. Subjects will not know which container contains which product. Each participant will also be given a form containing an analog pain scale for each leg. The participant will rate his or her pain in each leg separately on the day before exercise. Each subject will then be asked to perform calf raises using the following protocol:

• The participant removes shoes.

• Active range of motion of the ankle is measured bilaterally using a goniometer.

• He or she places the metatarsal portion of his or her foot on a step that is 7 inches above the floor. Handrails are provided for safety and comfort

• He or she then performs heel lifts by rising up on the stair using the foot on the stair, holds this for 2 seconds, then maximally dorsiflexes the foot for a count of 2 seconds. A metronome set to generate a tone every 2 seconds guides the pace of this.

• This is repeated 25 times, or until the subject is unable to complete a full cycle.

• He or she then performs the same sequence using the other leg.

• A second set of 20 repetitions is performed in each leg, followed by a final 15 repetitions.

• The gel is applied immediately after exercise to both lower legs. Subjects are instructed not to wash off the leg for at least one hour after application.

• The pain score is completed for each leg 24 hours later, and the gel is applied to each leg. Again, subjects are instructed to leave the gel undisturbed for at least one hour.

• Approximately 48 hours later the subject returns for measurement of ankle range of motion, again completes a pain score and applies the gel for a final time. Subjects are instructed to leave the gel on the legs for at least one hour.

• To measure muscle tenderness, a 1cm sphere is placed on the subject's mid-calf, and compressed by a standardized 5 pound weight. The subject provides a tenderness score for each leg using the same pain score.

• A final pain score is completed by each subject at approximately 72 hours.

Neither subjects nor the researchers doing the data collection or analysis will know which gel is associated with which formulation (placebo vs. Arnica). Controls are within-subjects.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 55
• Est. completion date: September 2008
• Est. primary completion date: September 2008
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• age 18 or older

• two fully functional legs

Exclusion Criteria:

• allergy or sensitivity to the ester family

• open wound or inflammatory condition on legs

• chronic or acute leg pain

• neuropathy involving one or both legs

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Arnica
• Exercise
• Muscles

Intervention

Drug:
• Arnica Montana
Applied to lower extremity once a day for 3 days
• placebo cream
placebo cream applied to leg daily for 3 days

Locations

Country	Name	City	State
United States	Memorial Family Medicine	Houston	Texas

Sponsors (1)

Lead Sponsor	Collaborator
The University of Texas Health Science Center, Houston

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Muscle soreness		24 - 72 hours	No
Secondary	Muscle tenderness		48 hours	No
Secondary	Range of motion of ankle joint		48 hours	No